Cargando…
Comparison of nadir serum concentrations in the extended dosing therapy of natalizumab between American and Japanese multiple sclerosis patients
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433394/ https://www.ncbi.nlm.nih.gov/pubmed/28607718 http://dx.doi.org/10.1177/2055217316632776 |
| _version_ | 1783236844322816000 |
|---|---|
| author | Tanaka, Masami Yokoyama, Kaho |
| author_facet | Tanaka, Masami Yokoyama, Kaho |
| author_sort | Tanaka, Masami |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5433394 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2016 |
| publisher | SAGE Publications |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-54333942017-06-12 Comparison of nadir serum concentrations in the extended dosing therapy of natalizumab between American and Japanese multiple sclerosis patients Tanaka, Masami Yokoyama, Kaho Mult Scler J Exp Transl Clin Letter to Editor SAGE Publications 2016-02-19 /pmc/articles/PMC5433394/ /pubmed/28607718 http://dx.doi.org/10.1177/2055217316632776 Text en © The Author(s) 2016 http://creativecommons.org/licenses/by-nc/3.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page(https://us.sagepub.com/en-us/nam/open-access-at-sage). |
| spellingShingle | Letter to Editor Tanaka, Masami Yokoyama, Kaho Comparison of nadir serum concentrations in the extended dosing therapy of natalizumab between American and Japanese multiple sclerosis patients |
| title | Comparison of nadir serum concentrations in the extended dosing therapy of natalizumab between American and Japanese multiple sclerosis patients |
| title_full | Comparison of nadir serum concentrations in the extended dosing therapy of natalizumab between American and Japanese multiple sclerosis patients |
| title_fullStr | Comparison of nadir serum concentrations in the extended dosing therapy of natalizumab between American and Japanese multiple sclerosis patients |
| title_full_unstemmed | Comparison of nadir serum concentrations in the extended dosing therapy of natalizumab between American and Japanese multiple sclerosis patients |
| title_short | Comparison of nadir serum concentrations in the extended dosing therapy of natalizumab between American and Japanese multiple sclerosis patients |
| title_sort | comparison of nadir serum concentrations in the extended dosing therapy of natalizumab between american and japanese multiple sclerosis patients |
| topic | Letter to Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433394/ https://www.ncbi.nlm.nih.gov/pubmed/28607718 http://dx.doi.org/10.1177/2055217316632776 |
| work_keys_str_mv | AT tanakamasami comparisonofnadirserumconcentrationsintheextendeddosingtherapyofnatalizumabbetweenamericanandjapanesemultiplesclerosispatients AT yokoyamakaho comparisonofnadirserumconcentrationsintheextendeddosingtherapyofnatalizumabbetweenamericanandjapanesemultiplesclerosispatients |